KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Prepaid Assets (2017 - 2025)

Moderna (MRNA) has disclosed Prepaid Assets for 9 consecutive years, with $408.0 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 603.45% to $408.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $408.0 million through Dec 2025, up 603.45% year-over-year, with the annual reading at $408.0 million for FY2025, 603.45% up from the prior year.
  • Prepaid Assets for Q4 2025 was $408.0 million at Moderna, down from $716.0 million in the prior quarter.
  • The five-year high for Prepaid Assets was $1.4 billion in Q1 2023, with the low at $31.0 million in Q2 2024.
  • Average Prepaid Assets over 5 years is $564.9 million, with a median of $498.5 million recorded in 2021.
  • The sharpest move saw Prepaid Assets crashed 97.4% in 2024, then soared 2364.52% in 2025.
  • Over 5 years, Prepaid Assets stood at $728.0 million in 2021, then tumbled by 93.96% to $44.0 million in 2022, then soared by 100.0% to $88.0 million in 2023, then tumbled by 34.09% to $58.0 million in 2024, then soared by 603.45% to $408.0 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $408.0 million, $716.0 million, and $764.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.